Global Medical Morphine Market, By Route of Administration (Oral, Injectables, Others), Application (Arthritis, Cancer, Myocardial Infarction, Kidney Stones, Diarrhea, Others), End Users (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Medical Morphine Market
The medical morphine market is expected to gain growth at a potential rate of 8.00% in the forecast period of 2021 to 2028 and is expected to reach a value of USD 34.87 billion by 2028. The increase in the cases of arthritis among the young as well as old population is the factors for the market growth.
Morphine is a narcotic analgesic which is found in naturally in the opium poppy plants and is used for the treatment of moderate to chronic pain. It acts on central nervous system to ease pain related to post surgery. Morphine is potent drug abuse owing to its sedative and euphoric nature.
The increase in prescription of painkillers for different illnesses such as arthritis, cardiovascular disorders and cancer is expected to accelerate the market growth in the forecast period of 2021 to 2028. Likewise, the vulnerable aging population and their medical conditions are also predictable to enhance the medical morphine market growth. Furthermore, the rise in patient population and rapid increase in the penetration by market players are also projected to drive the market growth rate. Also, the increase in incidence of cancer and other diseases such as cardiovascular illnesses and others are also expected to influence the medical morphine market growth globally.
In addition, the rapid rise in awareness regarding treatment and technological advancement are likely to create various new opportunities that will impact this medical morphine market growth in the forecast period of 2021 to 2028.
However, the addiction to morphine leading to drug abuse and introduction of generic drugs are expected to act as major restraints towards the growth of the medical morphine market, whereas the limited regulatory scenario in some countries can challenge the growth of the target market in the above mentioned forecast period.
This medical morphine market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the medical morphine market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Medical Morphine Market Scope and Market Size
The medical morphine market is segmented on the basis of route of administration, application, end users and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- Based on route of administration, the medical morphine market is segmented into oral, injectables and others.
- Based on application, the medical morphine market is segmented into arthritis, cancer, myocardial infarction, kidney stones, diarrhea and others.
- The medical morphine market is also segmented on the basis of end users into hospitals and clinics, ambulatory surgical centers, homecare and others.
- On the basis of distribution channel, the medical morphine market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others.
Medical Morphine Market Country Level Analysis
The medical morphine market is analyzed and market size information is provided by country by route of administration, application, end users and distribution channel as referenced above.
The countries covered in the medical morphine market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America leads the medical morphine market due to rise in the prevalence of arthritis and other inflammatory disorders and increase in the more elderly population. Asia-Pacific region is expected to expand at a significant growth rate in the forecast period of 2021 to 2028 because of the rise in incidence of chronic diseases such as cardiovascular disorders.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The medical morphine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Medical Morphine Market Share Analysis
The medical morphine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to medical morphine market.
The major players covered in the medical morphine market report are Mallinckrodt Pharmaceuticals, Alcaliber S.A, Sanofi, Johnson Matthey, Northeast Pharmaceutical Group Co., Ltd, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Pfizer Inc, Cipla Inc., Mylan N.V., Fresenius Kabi USA, DAIICHI SANKYO COMPANY, Allergan, Pacira BioSciences, Inc., Endo Pharmaceuticals Inc., Tris Pharma, Inc, Purdue Pharma L.P., VERVE HEALTH CARE LTD., Taj Pharmaceuticals Limited and AbbVie Inc., among other domestic and global players. Medical morphine market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-